MP
Manoj Pandey
Rowan University, Penn State College of Medicine, University of Lucknow, Pennsylvania State University College of Medicine
0000-0002-2767-2929
Employment
-
Rowan University Associate Professor2020 - Present
-
Rowan University Assistant Professor2016 - 2020
-
Penn State College of Medicine Assistant Profesor2013 - 2016
-
Pennsylvania State University College of Medicine Research Associate2012 - 2013
-
Pennsylvania State University College of Medicine Research Associate2009 - 2012
-
University of Texas MD Anderson Cancer Center Post Doctoral Fellow2005 - 2009
Education
-
University of Lucknow Ph.D.2000 - 2006
Projects & Funding
Projects & funding information is unavailable.
Publications (20)
- Saga of MCL1 inhibitors in multiple myeloma Save
- Tumor tough, therapy smarter: Rethinking CAR-T for pancreatic cancer Save
- Exploring Intracellular Signaling Responses to KS18, a Potent Mcl-1 Inhibitor, in Multiple Myeloma Save
- KS18, a Mcl-1 inhibitor, improves the effectiveness of bortezomib and overcomes resistance in refractory multiple myeloma by triggering intrinsic apoptosis Save
- Is it possible to treat melanoma by intercepting the CXCR4/CXCL12 pathway? Save
- Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma Patients Save
- Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells Save
- A New Hope for Multiple Myeloma: Harnessing the Power of Non-Cancer Medications Save
- Abstract 4670: KS18, an Mcl-1 inhibitor, triggers cell death and enhances the therapeutic efficacy of venetoclax in bortezomib-resistant multiple myeloma cells Save
- Drug Resistance Can be Overcome in Multiple Myeloma and Acute Myeloid Leukemia By Targeting Mcl-1 with the Small Chemical KS18 Save